<DOC>
	<DOC>NCT01449175</DOC>
	<brief_summary>The purpose of this study is to provide post market clinical follow-up (PMCF) to obtain long term safety and efficacy information about the AeriSeal System treatment in patients with advanced emphysema.</brief_summary>
	<brief_title>A Registry Study of the AeriSealÂ® System or Lung Volume Reduction in Patients With Advanced Emphysema</brief_title>
	<detailed_description>The purpose of this study is to provide post market clinical follow-up (PMCF) to obtain long term safety and efficacy information about the AeriSeal System treatment in patients with advanced homogeneous or heterogeneous emphysema.</detailed_description>
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<criteria>Confirmation of completion of Aeris' post market followup Continuation Study, 03C10001PLV.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>AeriSeal</keyword>
	<keyword>treatment</keyword>
	<keyword>device</keyword>
	<keyword>breathing</keyword>
	<keyword>COPD</keyword>
	<keyword>emphysema</keyword>
	<keyword>polymeric lung volume reduction (PLVR)</keyword>
	<keyword>biologic lung volume reduction (BLVR)</keyword>
	<keyword>heterogeneous</keyword>
	<keyword>homogeneous</keyword>
	<keyword>Respiratory Tract Diseases</keyword>
	<keyword>Lung Diseases</keyword>
	<keyword>Pulmonary Disease, Chronic Obstructive</keyword>
</DOC>